SEC Form D · filed September 25, 2020
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Jack W. Reich · Charlottesville, VADirectorKevin W. Schuyler, Cfa · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorJames W. Newman, Jr · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorJames K. Anderson · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorBankole A. Johnson · Charlottesville, VAExecNaman Shah · San Francisco, CADirectorJesse S. Jacobs · Playa Vista, CADirectorGina Mondo · Norwich, CTExec · DirectorPeter Feld · New York, NYDirectorSever Totia · New York, NYDirectorJason Bergsman · Playa Vista, CAExecMike Kerns · Playa Vista, CADirectorW. C. Mccollum · Los Angeles, CAExecKweli Washington · New York, NYDirectorUrsula Newman · London, United KingdomExecThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · DirectorCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorJamie Bateman · Cockeysville, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗